These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 1307604)
1. [Glomerulonephritis and superoxide dismutase]. Futenma A Rinsho Byori; 1992 Oct; 40(10):1027-33. PubMed ID: 1307604 [TBL] [Abstract][Full Text] [Related]
2. [Cu, Zn-superoxide dismutase, glutathione peroxidase location in kidney of IgA nephropathy]. Arao F; Yamada H; Katsumi K Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1047-53. PubMed ID: 1289604 [TBL] [Abstract][Full Text] [Related]
3. [Distribution of glutathione peroxidase in the glomeruli of IgA nephropathy]. Futenma A; Yamada H; Kato K; Taki K Rinsho Byori; 1994 Nov; 42(11):1177-81. PubMed ID: 7844890 [TBL] [Abstract][Full Text] [Related]
4. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012 [TBL] [Abstract][Full Text] [Related]
5. Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice. Wang LN; Fukui M; Shou I; Yaguchi Y; Funabiki K; Horikoshi S; Shirato I; Tomino Y J Clin Lab Anal; 1996; 10(6):394-8. PubMed ID: 8951608 [TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase activity in human glomerulonephritis. Kashem A; Endoh M; Yamauchi F; Yano N; Nomoto Y; Sakai H; Pronai L; Tanaka M; Nakazawa H Am J Kidney Dis; 1996 Jul; 28(1):14-22. PubMed ID: 8712210 [TBL] [Abstract][Full Text] [Related]
7. Cu/Zn- and Mn-superoxide dismutase distribution and concentration in adrenal tumors. Iwase K; Nagasaka A; Kato K; Itoh A; Jimbo S; Hibi Y; Kobayashi N; Yamamoto H; Seko T; Miura K J Surg Res; 2006 Sep; 135(1):150-5. PubMed ID: 16780879 [TBL] [Abstract][Full Text] [Related]
8. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971 [TBL] [Abstract][Full Text] [Related]
9. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733 [TBL] [Abstract][Full Text] [Related]
10. Plasma levels of superoxide dismutase and its isomers in patients with chronic renal disease. Futenma A; Yamada H; Kitano M; Miyai H; Fukatsu A; Kato K Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):371-6. PubMed ID: 8341015 [TBL] [Abstract][Full Text] [Related]
11. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy. Tsuboi N; Kawamura T; Ishii T; Utsunomiya Y; Hosoya T Nephrol Dial Transplant; 2009 Mar; 24(3):892-9. PubMed ID: 18922859 [TBL] [Abstract][Full Text] [Related]
12. [The incidence of renal diseases as diagnosed by biopsy in Hungary]. Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity. Pérez MJ; Cederbaum AI Hepatology; 2003 Nov; 38(5):1146-58. PubMed ID: 14578853 [TBL] [Abstract][Full Text] [Related]
14. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis. Qi X; Guy J; Nick H; Valentine J; Rao N Invest Ophthalmol Vis Sci; 1997 May; 38(6):1203-12. PubMed ID: 9152240 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of copper and zinc-superoxide dismutase (Cu, Zn-SOD) in meningiomas. Kurisaka M; Mori K Noshuyo Byori; 1993; 10(2):107-11. PubMed ID: 8220789 [TBL] [Abstract][Full Text] [Related]
16. [Relationship of mitogen-activated protein kinases activation with transdifferentiation of renal tubular epithelial cells in patients with IgA nephropathy]. Zhang M; Li XM Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):898-903. PubMed ID: 15329273 [TBL] [Abstract][Full Text] [Related]
17. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. McIntyre CW; Fluck RJ; Lambie SH Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033 [TBL] [Abstract][Full Text] [Related]
18. Histomorphometric correlates of renal failure in IgA nephropathy. Vleming LJ; de Fijter JW; Westendorp RG; Daha MR; Bruijn JA; van Es LA Clin Nephrol; 1998 Jun; 49(6):337-44. PubMed ID: 9696428 [TBL] [Abstract][Full Text] [Related]
19. Constitutive differences in Cu/Zn superoxide dismutase mRNA levels and activity in hemocytes of Biomphalaria glabrata (Mollusca) that are either susceptible or resistant to Schistosoma mansoni (Trematoda). Goodall CP; Bender RC; Broderick EJ; Bayne CJ Mol Biochem Parasitol; 2004 Oct; 137(2):321-8. PubMed ID: 15383302 [TBL] [Abstract][Full Text] [Related]
20. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis. Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]